KeyLemon raises $1.5m

The fresh capital will allow KeyLemon to further the development of its authentication technology, as well as fund the overall growth of the company and provide customer solutions.

The investment by Debiopharm and Swisscom marks the company's first capital injection from an external source.

Company
KeyLemon span out from the Idiap Research Institute in 2008. The company is headquartered in Martigny.

KeyLemon develops face and speaker recognition technology, designed for authentication solutions. A user can install KeyLemon's software onto their computer and, instead of entering a password to gain access, can smile at the webcam to be recognised by KeyLemon's software.

The company has partnerships with the Microsoft BizSpark programme, software watermarking solutions company Morpher and the European Commission-supported Tabula Rasa project.

People
Gilles Florey is the CEO of KeyLemon, as well as co-founder of the business alongside research and development manager Yann Rodriguez. Thierry Mauvernay is a delegate of Debiopharm's board, while Pär Lange is an investment officer at Swisscom.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Expansion
• Technology
• Switzerland